Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$156K Sell
3,411
-3,388
-50% -$176K 0.09% 200
2022
Q1
$412K Sell
6,799
-3,506
-34% -$229K 0.12% 213
2021
Q4
$793K Sell
10,305
-264
-2% -$16.3K 0.19% 116
2021
Q3
$543K Buy
10,569
+1,280
+14% +$71.1K 0.13% 169
2021
Q2
$528K Buy
9,289
+8,075
+665% +$445K 0.12% 173
2021
Q1
$66.4K Sell
1,214
-7,245
-86% -$390K 0.02% 486
2020
Q4
$447K Sell
8,459
-127
-1% -$5.64K 0.13% 185
2020
Q3
$341K Buy
+8,586
New +$452K 0.1% 167
2019
Q2
Sell
-1
Closed -$37 670
2019
Q1
$37 Sell
1
-907
-100% -$35.2K ﹤0.01% 604
2018
Q4
$30.8K Hold
908
0.01% 411
2018
Q3
$28.4K Sell
908
-6,273
-87% -$176K 0.01% 398
2018
Q2
$190K Buy
+7,181
New +$182K 0.03% 271
2017
Q3
Sell
-4,615
Closed -$115K 585
2017
Q2
$115K Sell
4,615
-10,152
-69% -$243K 0.02% 260
2017
Q1
$349K Buy
+14,767
New +$362K 0.08% 155

Other funds holding CIEN

Exane Derivatives's CIEN Position: Q2 2022 in Review

Exane Derivatives reduced its Ciena (CIEN) stake by 50% in Q2 2022, selling an estimated $176K and leaving 3,411 shares worth $156K. The position accounts for 0.09% of the portfolio, ranked #200.

Exane Derivatives first reported a position in CIEN in Q1 2017 and has held it in 14 quarters since. The position peaked at $793K in Q4 2021. 457 funds tracked by Wall St. Rank hold CIEN as of Q2 2022.

  • Exane Derivatives held 3,411 shares of Ciena worth $156K as of Q2 2022.
  • Exane Derivatives sold 3,388 Ciena shares in Q2 2022, an estimated $176K.
  • Ciena made up 0.09% of Exane Derivatives's portfolio in Q2 2022, its #200 holding.
  • Exane Derivatives first reported a position in Ciena in Q1 2017 and has held it in 14 quarters since.
  • Exane Derivatives's Ciena position peaked at $793K in Q4 2021.
  • 457 funds tracked by Wall St. Rank held Ciena as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.